As Seen In
Biomarker Intelligence Solutions
to Accelerate Precision Medicine
Amplion synthesizes the world’s biomedical knowledge with targeted machine learning to accelerate Precision Medicine and enable confident strategic decisioning in drug and diagnostic development.
Solutions for
Pharma
Mitigate drug program risk and increase likelihood of approval .
Solutions for
Diagnostics
Inform product strategy and Pharma opportunity identification.
Industry Insights
Companion Diagnostics Biomarker Trends
The CDx Trends Report details how biomarker-based tests are currently being used to identify patients and to guide drug dosing and safety.
Clinical Development Success Rates
Amplion, BIO, and BioMedTracker release new report on ground breaking role biomarkers have in tripling clinical trial Likelihood of Approval (LOA) rates.
Success in Precision Medicine
Success in Precision Medicine covers the growing importance of biomarkers in precision medicine and outlines the challenge of transitioning to targeted therapies.